• Senior pharmaceutical industry leader with progressive history of success achieving cost controls through establishment of outsourcing agreements as part of drug development and management efforts.
• Build, manage, and lead development and delivery of procurement management processes. Cultivate relationships with internal and external resources, as well as operating and clinical leaders to achieve commercial success on behalf of Novartis Pharmaceuticals.
• Serve as collaborative partner to business franchises, including adding ongoing value as integrated operational resource. Maintain complete understanding of franchise operations and create alignment between clinical and procurement activities.
Oversaw full lifecycle management of respiratory and cardiovascular assets, including negotiating contract terms and monitoring spending. Drafted and reviewed legal documents, negotiated financial and other terms and executed Global and North American clinical research contracts for Aventis’ service providers within Drug Innovation & Approval (DI&A) from pre-clinical through agency submission. Tracked and managed key performance indicators (KPIs) with preferred providers.
Highlighted Achievements: • Supported clinical teams in study start-up phases of clinical trials. − Negotiated one-shot, master and preferred provider agreements with clinical research organizations to include full-service clinical providers, central laboratory, core diagnostics, interactive voice response systems (IVR) and pharmaceutical development, including manufacturing, packaging and labeling of clinical supplies.
• Assisted in financial audits of new providers. Identified appropriate budget between DI&A controlling and Aventis project teams.
• Contributed as ad-hoc member of DI&A project teams to assist with resolving communication conflicts and relationship issues between Aventis project team and clinical research organization.
